Tetracycline Treatment Tolerability Trial | MicrobiomeTrials← Back to trialsNCT05219929
Tetracycline Treatment Tolerability Trial
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2022-11-02Est. Completion: 2026-06-09
Enrollment target: 60 participants Locations- Johns Hopkins Lyme Disease Research Center, Lutherville, Maryland, United States
Other microbiome trials you might be interested in
Lyme DiseasePost-Treatment Lyme DiseaseChronic Lyme DiseaseTick-Borne InfectionsPregnancy ComplicationsChild Development
The purpose of this pilot study is to assess the feasibility of longitudinal neurodevelopmental evaluation of fetuses an…
Washington D.C., United StatesEst. completion Dec 2026
TuberculosisAcute Coronary SyndromePulmonary Hypertension (Diagnosis)
Tuberculosis (TB) is a global pandemic that despite successful treatment and bacterial eradication can cause chronic ill…
Kota Kinabalu, MalaysiaEst. completion Jan 31, 2030